Merck   2Q Revenues: $9.8 billion (-11%) 2Q Earnings: $687 million (earnings were $2 billion 2Q14) YTD Revenues: $19.2 billion (-9%) YTD Earnings: $1.6 billion (-56%) Comments: Pharmaceutical sales were $8.6 billion, down 6% in the quarter. JANUVIA sales were $1.6 billion, up 1%. ZETIA / VYTORIN sales were down 16% to $955 million. GARDASIL sales were up 4% to $427 million. ISENTRESS sales dropped 17% to $375 million due to timing of tender purchases in the emerging markets and vol...